Ute Sartorius

Association of <i>KRAS</i> G13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab

Sabine Tejpar, Ilhan Celik, Michael Schlichting et al. · Journal of Clinical Oncology · 2012 · 352 citations

Upregulation of bcl‐2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines

Ute Sartorius, Peter H. Krammer · International Journal of Cancer · 2001 · 206 citations

Tumor Biology, Chemotherapy Resistance, Medicine +15

Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin

István Láng, Claus-Henning Köhne, Gunnar Folprecht et al. · European Journal of Cancer · 2012 · 70 citations · Full text

Influence of <i>KRAS </i>G13D mutations on outcome in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy with or without cetuximab.

Sabine Tejpar, Carsten Bokemeyer, İ. Çelik et al. · Journal of Clinical Oncology · 2011 · 43 citations

Kras Mutations, Neuro-oncology, Kras Wt Tumors +15

Deepness of response: A quantitative analysis of its impact on post-progression survival time after first-line treatment in patients with mCRC.

Ulrich Mansmann, Ute Sartorius, Ruediger P. Laubender et al. · Journal of Clinical Oncology · 2013 · 42 citations

Surgical Oncology, Post-progression Survival Time, Disease Progression +20